← FDA Drug Approvals (Drugs@FDA)
MELPHALAN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALVOGEN · Approved 2017-03-22
Drug application
- FDA Application #
ANDA207809- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- MELPHALAN
- Generic name
- Melphalan
- Active ingredients
- MELPHALAN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- ALVOGEN
- First approval
- 2017-03-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown